Amgen Plays Both Sides As It Builds Out Inflammation Biosimilars

Remicade Biosimilar Avsola Launched In July

 
• By Dean Rudge
chess
Amgen's biosimilar strategy was to embed products in its existing teams • Source: Shutterstock

More from Biosimilars

More from Products